2016
Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India
Mane A, Sahasrabuddhe VV, Nirmalkar A, Risbud AR, Sahay S, Bhosale RA, Vermund SH, Mehendale SM. Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India. Journal Of Clinical Virology 2016, 88: 26-32. PMID: 28152432, PMCID: PMC5441893, DOI: 10.1016/j.jcv.2016.10.013.Peer-Reviewed Original ResearchConceptsHIV-seropositive womenCervical HPV genotypesHPV genotypesClearance rateHPV infectionAge-related hormonal changesRoche Linear Array HPVAlpha-7 speciesAntiretroviral therapy statusCarcinogenic HPV genotypesCervical HPV infectionGenotype-specific prevalenceLinear Array HPVAge of participantsCD4 countHPV incidenceImmunologic factorsDeterminants of incidenceHPV typesTherapy statusProspective studyCervical samplesIncidence rateHormonal changesEtiologic studies
2015
Implementation and Operational Research
Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP. Implementation and Operational Research. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2015, 70: e20-e26. PMID: 26322673, PMCID: PMC4791059, DOI: 10.1097/qai.0000000000000685.Peer-Reviewed Original ResearchConceptsUnknown HIV serostatusHIV serostatusYoung womenCervical cancerOlder womenHIV/AIDS care programsCervical cancer prevention programsInvasive cervical cancer casesRisk of ICCHIV-seronegative womenHIV-seropositive womenIndependent risk factorCancer prevention programsCervical cancer casesMultivariable logistic regressionAIDS care programsLifetime sexual partnersHIV infectionSaharan AfricaRisk factorsCancer casesAge 35High riskICC casesCare program
2013
Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a ‘Screen-And-Treat’ Program Integrated with HIV/AIDS Care in Zambia
Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP. Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a ‘Screen-And-Treat’ Program Integrated with HIV/AIDS Care in Zambia. PLOS ONE 2013, 8: e74607. PMID: 24058599, PMCID: PMC3776830, DOI: 10.1371/journal.pone.0074607.Peer-Reviewed Original ResearchConceptsCervical cancer screening servicesCancer screening servicesHIV-seronegative womenHIV serostatusScreening servicesHIV/AIDS care programsCervical cancer prevention programsCervical cancer prevention servicesCervical cancer screening programsHIV/AIDS careHIV-seropositive womenCancer prevention servicesCancer prevention programsCancer screening programsAIDS care programsProportion of womenPatterns of utilizationHIV-seropositiveCervical cancerSaharan AfricaTest positivityPositivity rateAIDS careScreening programMultivariable modeling
1992
Genital papillomavirus infection and cervical dysplasia—opportunistic complications of hiv infection
Laga M, Icenogle J, Marsella R, Manoka A, Nzila N, Ryder R, Vermund S, Heyward W, Nelson A, Reeves W. Genital papillomavirus infection and cervical dysplasia—opportunistic complications of hiv infection. International Journal Of Cancer 1992, 50: 45-48. PMID: 1309459, DOI: 10.1002/ijc.2910500110.Peer-Reviewed Original ResearchConceptsCervical intra-epithelial neoplasiaHuman genital papillomavirusesHPV infectionOpportunistic complicationsSeronegative womenHIV infectionHPV typesCervical cancerPap smearHuman immunodeficiency virus (HIV) infectionHIV-seropositive womenHPV DNA testingImmunodeficiency virus infectionIntra-epithelial neoplasiaGenital papillomavirus infectionAno-genital cancersGenital HPV typesCervicovaginal lavageSeropositive womenHIV seropositivityPapillomavirus infectionCervical diseaseCervical dysplasiaHPV DNAImmunodeficiency syndrome